Literature DB >> 19144367

An examination of the activity of expired and mistreated commercial Australian antivenoms.

Margaret A O'Leary1, Rachelle S Kornhauser, Wayne C Hodgson, Geoffrey K Isbister.   

Abstract

Expired antivenoms may be useful in countries where snake envenoming is common and supplies are limited. This study examined the activity of expired Australasian antivenoms. Expired CSL snake antivenoms, including taipan, brown snake and polyvalent antivenoms, were used. The most current antivenom was used as the reference to compare expired antivenoms. Binding activity was assessed by enzyme immunoassay. Neutralisation of venom clotting effects was assessed by a modified clotting test using changes in optical density. Neutralisation of the in vitro neurotoxic effects of taipan venom was determined using a chick biventer cervicis nerve-muscle preparation. All antivenom batches remained active, with gradual deterioration in activity and binding over time. All batches of taipan antivenom at concentrations equivalent to the administration of one vial (including one 15 years expired) prevented clotting by taipan venom. Brown snake antivenoms also prevented clotting, except two that were 10 years old. All expired taipan/polyvalent antivenom prevented in vitro neurotoxicity at concentrations consistent with antivenom treatment. Freeze-thawing the antivenom or leaving it at room temperature for 3 days caused only small decreases in activity. CSL antivenoms are more robust than indicated on their label and maintain useful activity long past their nominated expiry dates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144367     DOI: 10.1016/j.trstmh.2008.11.011

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  In Vitro Neutralization of the Myotoxicity of Australian Mulga Snake (Pseudechis australis) and Sri Lankan Russell's Viper (Daboia russelii) Venoms by Australian and Indian Polyvalent Antivenoms.

Authors:  Prabhani Thakshila; Wayne C Hodgson; Geoffrey K Isbister; Anjana Silva
Journal:  Toxins (Basel)       Date:  2022-04-26       Impact factor: 5.075

2.  Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies.

Authors:  Kalana Maduwage; Anjana Silva; Margaret A O'Leary; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 3.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

4.  Pan-American Lancehead Pit-Vipers: Coagulotoxic Venom Effects and Antivenom Neutralisation of Bothrops asper and B. atrox Geographical Variants.

Authors:  Lachlan A Bourke; Christina N Zdenek; Edgar Neri-Castro; Melisa Bénard-Valle; Alejandro Alagón; José María Gutiérrez; Eladio F Sanchez; Matt Aldridge; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2021-01-22       Impact factor: 4.546

5.  A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms.

Authors:  Lorenzo Seneci; Christina N Zdenek; Abhinandan Chowdhury; Caroline F B Rodrigues; Edgar Neri-Castro; Melisa Bénard-Valle; Alejandro Alagón; Bryan G Fry
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

6.  What is the impact of snakebite envenoming on domestic animals? A nation-wide community-based study in Nepal and Cameroon.

Authors:  Isabelle Bolon; Sara Babo Martins; Carlos Ochoa; Gabriel Alcoba; María Herrera; Henri Magloire Bofia Boyogueno; Barun Kumar Sharma; Manish Subedi; Bhupendra Shah; Franck Wanda; Sanjib Kumar Sharma; Armand Seraphin Nkwescheu; Nicolas Ray; François Chappuis; Rafael Ruiz de Castañeda
Journal:  Toxicon X       Date:  2021-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.